Clinical application of Tongqiao Biyan Granules in allergic rhinitis patients with syndrome of wind-heat invading lung
CHEN Lu1 HE Xingbo2 JI Shiliang3 LIN Zhiqiang1▲
1.Department of Otolaryngology, Head, and Neck Surgery, North District, Suzhou Municipal Hospital, Jiangsu Province, Suzhou 215008, China; 2.Department of Otolaryngology, Head, and Neck Surgery, Liangjiang New District People’s Hospital, Chongqing 401135, China; 3.Department of Pharmacy, Suzhou Science and Technology City Hospital, Jiangsu Province, Suzhou 215153, China
Abstract：Objective To observe the clinical application of Tongqiao Biyan Granules in allergic rhinitis patients with syndrome of wind-heat invading lung. Methods A total of 102 allergic rhinitis patients with syndrome of wind-heat invading lung admitted to the North District, Suzhou Municipal Hospital, Jiangsu Province from August 2019 to August 2022 were selected and divided into combined group (51 cases) and routine group (51 cases) by random number table method. The routine group was treated with Levocetirizine, and the combined group was treated with Levocetirizine combined with Tongqiao Biyan Granules. Both groups were treated for three weeks. The clinical efficacy, and symptom score, sign score, olfactory recognition threshold before and after treatment were compared between the two groups, and the occurrence of adverse reactions were recorded. Results The clinical effect of the combined group was better than that of the routine group, and the difference was statistically significant (P＜0.05). After treatment, the symptoms, signs scores, and olfactory recognition threshold of the two groups were lower than those before treatment, and those of combined group were lower than those of control group, and the differences were statistically significant (P＜0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P＞0.05). Conclusion Tongqiao Biyan Granules combined with Levocetirizine can improve the clinical symptoms of allergic rhinitis patients with syndrome of wind-heat invading lung, and can reduce the olfaction recognition threshold of patients, and is safe, worthy of promotion.
2023, Vol. 20 
京公网安备 11010502046598号